Literature DB >> 8509547

Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction.

M R Starling1, M M Kirsh, D G Montgomery, M D Gross.   

Abstract

OBJECTIVES: We tested the hypotheses that left ventricular chamber elastance would detect impaired contractile function in patients with long-term mitral regurgitation and a normal ejection fraction and that these patients would have unique temporal left ventricular size and ejection fraction responses to mitral valve surgery.
BACKGROUND: Although it has been suggested that left ventricular contractile function may begin deteriorating in patients with long-term mitral regurgitation whereas ejection fraction remains normal, no data exist in humans.
METHODS: We studied 11 control patients and 28 patients with long-term mitral regurgitation using micromanometer-measured pressures, biplane contrast cineventriculography and radionuclide angiography under control conditions and with alterations in load during right atrial pacing to calculate left ventricular chamber elastance and myocardial stiffness.
RESULTS: The patients with mitral regurgitation were classified into subgroups: Group I, normal contractile function; Group II, impaired contractile function (reduced Emax) but normal ejection fraction, and Group III, impaired contractile function (reduced Emax) with reduced systolic myocardial stiffness. Twenty-two of the patients with mitral regurgitation underwent mitral valve surgery. In Group I, comparable decreases in left ventricular volume indexes (p < 0.01 and p = 0.05, respectively) were associated with no change in ejection fraction at 3 months and 1 year. In contrast, in Group II, reductions in volume indexes (p < 0.0001 and p < 0.001) were associated with a short-term decrease in ejection fraction (p < 0.001) that recovered at 1 year (p < 0.01 vs. short-term). Finally, in Group III, variable responses in volume indexes were associated with a consistent decrease in ejection fraction at 3 months and 1 year.
CONCLUSIONS: An analysis of left ventricular chamber elastance provides data to support the concepts that 1) contractile function is impaired in some patients with long-term mitral regurgitation and a normal ejection fraction, 2) impaired contractile function may not be irreversible in all of these patients, and 3) an earlier consideration of mitral valve surgery may be warranted to preserve contractile function in these patients.

Entities:  

Mesh:

Year:  1993        PMID: 8509547     DOI: 10.1016/0735-1097(93)90840-w

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  Left ventricular end-systolic stress/diameter relation as a contractility index and as a predictor of survival. Independence of preload after normalization for end-diastolic diameter.

Authors:  Ioannis Moyssakis; Nikitas Moschos; Filipos Triposkiadis; Youssef Hallaq; Nick Pantazopoulos; Athanasios Aessopos; Miltiades Kolettis
Journal:  Heart Vessels       Date:  2005-09       Impact factor: 2.037

Review 2.  Management decisions in valvular heart disease: the role of radionuclide-based assessment of ventricular function and performance.

Authors:  J S Borer; D Wencker; C Hochreiter
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

3.  Management of Mitral Regurgitation Due to Mitral Prolapse.

Authors:  Marc D. Tischler; Atul Aggarwal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

4.  Area strain from 3D speckle-tracking echocardiography as an independent predictor of early symptoms or ventricular dysfunction in asymptomatic severe mitral regurgitation with preserved ejection fraction.

Authors:  Eduardo Casas-Rojo; Covadonga Fernández-Golfin; José Luis Moya-Mur; Ariana González-Gómez; Ana García-Martín; Laura Morán-Fernández; Daniel Rodríguez-Muñoz; José Julio Jiménez-Nacher; David Martí Sánchez; José Luis Zamorano Gómez
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-09       Impact factor: 2.357

Review 5.  Drug Therapy for Heart Valve Diseases.

Authors:  Jeffrey S Borer; Abhishek Sharma
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

Review 6.  Mitral valve reconstruction in the patient with heart failure.

Authors:  S F Bolling
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

7.  Use of tissue Doppler echocardiography in early detection of left ventricular systolic dysfunction in patients with mitral regurgitation.

Authors:  Cem Nazli; Ozan Kinay; Oktay Ergene; Turan Yavuz; Omer Gedikli; Yesim Hoscan; Mehmet Ozaydin; Ahmet Altinbas; Abdullah Dogan; Halil Kahraman; Gurkan Acar
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

8.  The use of exercise echocardiography in the evaluation of mitral regurgitation.

Authors:  Kibar Yared; Kaitlyn My-Tu Lam; Judy Hung
Journal:  Curr Cardiol Rev       Date:  2009-11

9.  Comparison of N-terminal pro B-natriuretic Peptide and echocardiographic indices in patients with mitral regurgitation.

Authors:  Shokoufeh Hajsadeghi; Niloufar Samiei; Masoud Moradi; Maleki Majid; Ladan Kashani; Afsaneh Amani; Arezoo Salami; Melika Asefi; Negin Farsi
Journal:  Clin Med Insights Cardiol       Date:  2010-11-30

10.  Mitral regurgitation: has another magic bullet bitten the dust?

Authors:  Jeffrey S Borer
Journal:  Circ Heart Fail       Date:  2013-07       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.